Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00840294 · ClinicalTrials.gov registry record · Phase 3
Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)
A Phase 3 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 3
- Development phase
- 85
- Enrollment target
NCT00840294 is a Phase 3 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 85 participants.
The verdict
NCT00840294, a Phase 3 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of an empiric course of antibiotics for men with an elevated prostate-specific antigen (PSA) level.
Interventions
- DRUG Ciprofloxacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00840294
The ClinicalTrials.gov registry entry for NCT00840294 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ciprofloxacin is the first listed.
NCT00840294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00840294 about?
NCT00840294 is a clinical study titled "Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)". The purpose of this study is to assess the impact of an empiric course of antibiotics for men with an elevated prostate-specific antigen (PSA) level.
What is the current status of trial NCT00840294?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 85 participants. The study started on 2009-01. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00840294?
The interventions under investigation include: Ciprofloxacin (DRUG).
Who is sponsoring clinical trial NCT00840294?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.